A Delhi court dismissed the CBI's case against Kejriwal, criticizing the use of "South Group" in the charge sheet as prejudicial and divisive. | Latest News Delhi ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Stating that \"accountability needs to be fixed\", the special court on Friday recommended a departmental inquiry against the ...

Eckert & Ziegler SE and Molecular Partners AG have entered into a partnership to develop and potentially manufacture DARPin-based radiopharmaceutical therapies for cancer treatment. Eckert & Ziegler ...

Ruling that there was no “overarching conspiracy” or “criminal intent” in the framing of the Delhi excise policy, a Delhi ...

Court discredits CBI's excise policy case against AAP leaders, citing lack of evidence and warning against biased language.

A Delhi court, while discharging Arvind Kejriwal and others in the liquor policy case, criticised the CBI for using the term ...

Delhi excise policy case sees court discharge Arvind Kejriwal and Manish Sisodia, criticising CBI’s reliance on repeated ...

Zura Bio Limited (Nasdaq: ZURA) ("Zura"), a clinical-stage biotechnology company developing novel and differentiated ...

A Delhi court, which on Friday discharged former chief minister Arvind Kejriwal and 21 others in the politically-charged liquor-policy case, expressed its displeasure with the CBI for using the phrase ...

Chinese pharmaceutical company WuXi XDC is partnering with U.S. biotech startup Earendil Labs in a deal it says could be worth up to $885 million. Under the agreement, Hong Kong-listed WuXi will grant ...

A Delhi court on Friday discharged former Delhi chief minister Arvind Kejriwal, his deputy Manish Sisodia and 21 others in the politically charged liquor policy case, pulling up the CBI by saying its ...